111 related articles for article (PubMed ID: 28418440)
21. Ebolavirus interferon antagonists-protein interaction perspectives to combat pathogenesis.
Banerjee A; Pal A; Pal D; Mitra P
Brief Funct Genomics; 2018 Nov; 17(6):392-401. PubMed ID: 29140409
[TBL] [Abstract][Full Text] [Related]
22. Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets.
Fanunza E; Frau A; Corona A; Tramontano E
Infect Disord Drug Targets; 2019; 19(4):362-374. PubMed ID: 30468131
[TBL] [Abstract][Full Text] [Related]
23. A single phosphorodiamidate morpholino oligomer targeting VP24 protects rhesus monkeys against lethal Ebola virus infection.
Warren TK; Whitehouse CA; Wells J; Welch L; Heald AE; Charleston JS; Sazani P; Reid SP; Iversen PL; Bavari S
mBio; 2015 Feb; 6(1):. PubMed ID: 25670780
[TBL] [Abstract][Full Text] [Related]
24. The Ebola Virus Interferon Antagonist VP24 Undergoes Active Nucleocytoplasmic Trafficking.
Harrison AR; David CT; Rawlinson SM; Moseley GW
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452514
[TBL] [Abstract][Full Text] [Related]
25. Expression of the Ebola Virus VP24 Protein Compromises the Integrity of the Nuclear Envelope and Induces a Laminopathy-Like Cellular Phenotype.
Vidal S; Sánchez-Aparicio M; Seoane R; El Motiam A; Nelson EV; Bouzaher YH; Baz-Martínez M; García-Dorival I; Gonzalo S; Vázquez E; Vidal A; Muñoz-Fontela C; García-Sastre A; Rivas C
mBio; 2021 Aug; 12(4):e0097221. PubMed ID: 34225493
[TBL] [Abstract][Full Text] [Related]
26. In Silico Study of Plant Polyphenols' Interactions with VP24-Ebola Virus Membrane-associated Protein.
Pleško S; Volk H; Lukšič M; Podlipnik Č
Acta Chim Slov; 2015; 62(3):555-64. PubMed ID: 26454589
[TBL] [Abstract][Full Text] [Related]
27. A simulation investigation on interaction mechanism between Ebola nucleoprotein and VP35 peptide.
Ding JN; Zhang YJ; Zhong H; Ao CC; Han JG
J Biomol Struct Dyn; 2018 Mar; 36(4):1009-1028. PubMed ID: 28298161
[TBL] [Abstract][Full Text] [Related]
28. Development and Validation of a Novel Dual Luciferase Reporter Gene Assay to Quantify Ebola Virus VP24 Inhibition of IFN Signaling.
Fanunza E; Frau A; Sgarbanti M; Orsatti R; Corona A; Tramontano E
Viruses; 2018 Feb; 10(2):. PubMed ID: 29495311
[TBL] [Abstract][Full Text] [Related]
29. Importin-α7 Is Involved in the Formation of Ebola Virus Inclusion Bodies but Is Not Essential for Pathogenicity in Mice.
Gabriel G; Feldmann F; Reimer R; Thiele S; Fischer M; Hartmann E; Bader M; Ebihara H; Hoenen T; Feldmann H
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S316-21. PubMed ID: 26185094
[TBL] [Abstract][Full Text] [Related]
30. Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome.
Watanabe S; Noda T; Halfmann P; Jasenosky L; Kawaoka Y
J Infect Dis; 2007 Nov; 196 Suppl 2():S284-90. PubMed ID: 17940962
[TBL] [Abstract][Full Text] [Related]
31. Novel activities by ebolavirus and marburgvirus interferon antagonists revealed using a standardized in vitro reporter system.
Guito JC; Albariño CG; Chakrabarti AK; Towner JS
Virology; 2017 Jan; 501():147-165. PubMed ID: 27930961
[TBL] [Abstract][Full Text] [Related]
32. The Minor Matrix Protein VP24 from Ebola Virus Lacks Direct Lipid-Binding Properties.
Su Y; Stahelin RV
Viruses; 2020 Aug; 12(8):. PubMed ID: 32784484
[TBL] [Abstract][Full Text] [Related]
33. Ebolavirus protein VP24 interferes with innate immune responses by inhibiting interferon-λ1 gene expression.
He F; Melén K; Maljanen S; Lundberg R; Jiang M; Österlund P; Kakkola L; Julkunen I
Virology; 2017 Sep; 509():23-34. PubMed ID: 28595092
[TBL] [Abstract][Full Text] [Related]
34. Contribution of Sec61α to the life cycle of Ebola virus.
Iwasa A; Halfmann P; Noda T; Oyama M; Kozuka-Hata H; Watanabe S; Shimojima M; Watanabe T; Kawaoka Y
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S919-26. PubMed ID: 21987770
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of Ebola virus VP24 impairs viral nucleocapsid assembly and prevents virus replication.
Mateo M; Carbonnelle C; Martinez MJ; Reynard O; Page A; Volchkova VA; Volchkov VE
J Infect Dis; 2011 Nov; 204 Suppl 3():S892-6. PubMed ID: 21987766
[TBL] [Abstract][Full Text] [Related]
36. Changes associated with Ebola virus adaptation to novel species.
Pappalardo M; Reddin IG; Cantoni D; Rossman JS; Michaelis M; Wass MN
Bioinformatics; 2017 Jul; 33(13):1911-1915. PubMed ID: 28200119
[TBL] [Abstract][Full Text] [Related]
37. Insight into the binding modes of Lassa nucleoprotein complexed with ssRNA by molecular dynamic simulations and free energy calculations.
Zhang Y; Chen H; Han JG
J Biomol Struct Dyn; 2015; 33(5):946-60. PubMed ID: 24824824
[TBL] [Abstract][Full Text] [Related]
38. Fold prediction of VP24 protein of Ebola and Marburg viruses using de novo fragment assembly.
Lee MS; Lebeda FJ; Olson MA
J Struct Biol; 2009 Aug; 167(2):136-44. PubMed ID: 19447180
[TBL] [Abstract][Full Text] [Related]
39. The ebolavirus VP24 interferon antagonist: know your enemy.
Zhang AP; Abelson DM; Bornholdt ZA; Liu T; Woods VL; Saphire EO
Virulence; 2012 Aug; 3(5):440-5. PubMed ID: 23076242
[TBL] [Abstract][Full Text] [Related]
40. Ebola virus VP24 interacts with NP to facilitate nucleocapsid assembly and genome packaging.
Banadyga L; Hoenen T; Ambroggio X; Dunham E; Groseth A; Ebihara H
Sci Rep; 2017 Aug; 7(1):7698. PubMed ID: 28794491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
